Team systematically modifies glyceraldehyde derivative JX22 for improved anti-heart failure efficacy and safety

[Health - Medical Xpress - latest medical and]

Sodium-glucose cotransporter 2 inhibitors are a class of glucose-lowering drugs known for robust cardiovascular protective properties. However, the side effects induced by sodium-glucose cotransporter 2 inhibition limit application in cardiovascular medicine.

Continue reading...